• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织型纤溶酶原激活剂(rt-PA)与肝素治疗深静脉血栓形成的随机试验结果

Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial.

作者信息

Turpie A G, Levine M N, Hirsh J, Ginsberg J S, Cruickshank M, Jay R, Gent M

机构信息

Department of Medicine, McMaster University, Hamilton, Canada.

出版信息

Chest. 1990 Apr;97(4 Suppl):172S-175S.

PMID:2108855
Abstract

We performed a randomized trial comparing two dosing regimens of recombinant tissue plasminogen activator (rt-PA) plus heparin vs heparin alone in the treatment of acute proximal deep vein thrombosis in 83 patients. Of 12 patients who received 0.5 mg/kg rt-PA plus heparin over 4 h, seven (58 percent) had greater than 50 percent lysis of the thrombus, compared with none of 12 who received placebo plus heparin (p = 0.002). Of 28 patients who received 0.5 mg/kg rt-PA over 8 h, repeated in 24 h, six (21 percent) had greater than 50 percent lysis, compared with two (7 percent) of 30 patients who received placebo plus heparin (p = 0.11). The 4-h infusion of rt-PA produced a 40 percent reduction and the 8-h infusion an 11 percent reduction in plasma fibrinogen concentration. At long-term follow-up, three (25 percent) of 12 patients in whom greater than 50 percent lysis was achieved had symptoms of the postphlebitic syndrome, compared with 19 (56 percent) of 34 patients in whom lysis was less than 50 percent (p = 0.07).

摘要

我们进行了一项随机试验,比较重组组织型纤溶酶原激活剂(rt-PA)加肝素的两种给药方案与单独使用肝素治疗83例急性近端深静脉血栓形成的疗效。在12例接受4小时内0.5mg/kg rt-PA加肝素治疗的患者中,7例(58%)血栓溶解超过50%,而12例接受安慰剂加肝素治疗的患者中无一例血栓溶解超过50%(p = 0.002)。在28例接受8小时内0.5mg/kg rt-PA治疗(24小时后重复给药)的患者中,6例(21%)血栓溶解超过50%,而30例接受安慰剂加肝素治疗的患者中有2例(7%)血栓溶解超过50%(p = 0.11)。rt-PA 4小时输注使血浆纤维蛋白原浓度降低40%,8小时输注使血浆纤维蛋白原浓度降低11%。在长期随访中,血栓溶解超过50%的12例患者中有3例(25%)出现了静脉炎后综合征症状,而血栓溶解低于50%的34例患者中有19例(56%)出现了静脉炎后综合征症状(p = 0.07)。

相似文献

1
Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial.组织型纤溶酶原激活剂(rt-PA)与肝素治疗深静脉血栓形成的随机试验结果
Chest. 1990 Apr;97(4 Suppl):172S-175S.
2
Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis.组织型纤溶酶原激活剂治疗近端深静脉血栓形成的随机对照试验
Am J Med. 1990 Mar;88(3):235-40. doi: 10.1016/0002-9343(90)90148-7.
3
Studies on the medical treatment of deep vein thrombosis.深静脉血栓形成的医学治疗研究。
Acta Med Scand Suppl. 1985;704:1-68.
4
Comparative results of thrombolysis treatment with rt-PA and urokinase: a pilot study.
Vasa. 1998 Aug;27(3):167-71.
5
Multicenter pilot study of the efficacy and safety of systemic rt-PA administration in the treatment of deep vein thrombosis of the lower extremities and/or pelvis.全身应用rt-PA治疗下肢和/或盆腔深静脉血栓形成的疗效与安全性多中心前瞻性研究
Thromb Res. 1989 Jul 1;55(1):5-11. doi: 10.1016/0049-3848(89)90451-9.
6
[Thrombolytic therapy of deep venous thrombosis with rt-PA].
Klin Wochenschr. 1988;66 Suppl 12:137-42.
7
Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.在犬动静脉联合血栓形成模型中组织型纤溶酶原激活剂与纤溶酶原激活剂抑制剂-1抗性糖基化变体的溶栓特性比较
Thromb Haemost. 1994 Jul;72(1):98-104.
8
Double-blind, randomized comparison of systemic continuous infusion of 0.25 versus 0.50 mg/kg/24 h of alteplase over 3 to 7 days for treatment of deep venous thrombosis in heparinized patients: results of the European Thrombolysis with rt-PA in Venous Thrombosis (ETTT) trial.在肝素化患者中,比较3至7天内全身持续输注0.25毫克/千克/24小时与0.50毫克/千克/24小时阿替普酶治疗深静脉血栓形成的双盲随机对照研究:欧洲rt-PA静脉血栓溶解(ETTT)试验结果
Thromb Haemost. 1992 Mar 2;67(3):306-9.
9
Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis.重组组织型纤溶酶原激活剂治疗近端深静脉血栓形成的给药方案比较。
J Lab Clin Med. 1992 May;119(5):485-95.
10
Fibrinolytic therapy of deep vein thrombosis with continuous intravenous infusion of a recombinant tissue plasminogen activator.采用重组组织型纤溶酶原激活剂持续静脉输注对深静脉血栓形成进行溶栓治疗。
Semin Thromb Hemost. 1991 Jan;17(1):48-54. doi: 10.1055/s-2007-1002589.

引用本文的文献

1
Citrullinated fibrinogen forms densely packed clots with decreased permeability.瓜氨酸化纤维蛋白原形成致密的血栓,其通透性降低。
J Thromb Haemost. 2022 Dec;20(12):2862-2872. doi: 10.1111/jth.15875. Epub 2022 Sep 27.
2
Thrombolytic strategies versus standard anticoagulation for acute deep vein thrombosis of the lower limb.下肢急性深静脉血栓形成的溶栓策略与标准抗凝治疗的比较。
Cochrane Database Syst Rev. 2021 Jan 19;1(1):CD002783. doi: 10.1002/14651858.CD002783.pub5.
3
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.
美国血液学会2020年静脉血栓栓塞管理指南:深静脉血栓形成和肺栓塞的治疗
Blood Adv. 2020 Oct 13;4(19):4693-4738. doi: 10.1182/bloodadvances.2020001830.
4
The safety and efficacy of pharmaco-mechanical thrombolysis in lower-extremity deep venous thrombosis.下肢深静脉血栓形成的药物机械溶栓的安全性和有效性。
Cardiovasc J Afr. 2020 Nov-Dec;31(6):286-290. doi: 10.5830/CVJA-2020-020. Epub 2020 Jun 19.
5
Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis.溶栓治疗静脉血栓栓塞事件:系统评价与荟萃分析。
Blood Adv. 2020 Apr 14;4(7):1539-1553. doi: 10.1182/bloodadvances.2020001513.
6
Outcome of Acute Deep Venous Thrombosis Using Standard Treatment versus Thrombolytics: A Literature Review.急性深静脉血栓形成采用标准治疗与溶栓治疗的结局:文献综述
Int J Hematol Oncol Stem Cell Res. 2019 Oct 1;13(4):201-207.
7
Catheter-directed thrombolysis of deep vein thrombosis: literature review and practice considerations.导管定向溶栓治疗深静脉血栓形成:文献综述与实践考量
Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S228-S237. doi: 10.21037/cdt.2017.09.15.
8
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.药物机械性导管定向溶栓治疗深静脉血栓形成
N Engl J Med. 2017 Dec 7;377(23):2240-2252. doi: 10.1056/NEJMoa1615066.
9
Thrombolysis for acute deep vein thrombosis.急性深静脉血栓形成的溶栓治疗
Cochrane Database Syst Rev. 2016 Nov 10;11(11):CD002783. doi: 10.1002/14651858.CD002783.pub4.
10
Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis.髂股深静脉血栓形成的药物机械性血栓切除术
Cochrane Database Syst Rev. 2016 Nov 4;11(11):CD011536. doi: 10.1002/14651858.CD011536.pub2.